Cytek Biosciences, Inc.
CTKB- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001831915
No open-market purchases or sales by Cytek Biosciences, Inc. insiders were filed in the last 90 days; 154 institutions reported holding it in 13F filings for Q2 2026, worth $361.0M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Cytek Biosciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 102
- −1 vs. Q4 2022
- Shares held
- 68.5M
- +4.45M (+7.0%) vs. Q4 2022
- Total value
- $629.6M
- −$24.5M (−3.7%) vs. Q4 2022
- New holders
- 16
- 41 more added
- Sold out
- 17
- 34 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTKB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 154 | $361.0M |
| Q1 2026 | 165 | $371.8M |
| Q4 2025 | 155 | $414.3M |
| Q3 2025 | 153 | $277.4M |
| Q2 2025 | 158 | $270.0M |
| Q1 2025 | 161 | $310.8M |
| Q4 2024 | 153 | $501.4M |
| Q3 2024 | 136 | $415.3M |
| Q2 2024 | 129 | $425.1M |
| Q1 2024 | 125 | $540.9M |
| Q4 2023 | 105 | $719.9M |
| Q3 2023 | 107 | $427.7M |
| Q2 2023 | 101 | $657.9M |
| Q1 2023 | 102 | $629.6M |
| Q4 2022 | 103 | $654.1M |
| Q3 2022 | 88 | $898.5M |
| Q2 2022 | 85 | $567.8M |
| Q1 2022 | 74 | $514.5M |
| Q4 2021 | 52 | $571.9M |
| Q3 2021 | 54 | $733.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Cytek Biosciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bogart Wealth, LLC | 24 | $221 | 0.00% | +24 | New |
| Covestor Ltd | 14 | $0 | 0.00% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −812,662−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −420,749−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −344,529−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −72,179−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −32,796−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −19,881−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −16,736−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −15,863−100.0% | Sold out |
| Innovis Asset Management LLC | 0 | $0 | 0.00% | −14,565−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −14,102−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −12,882−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −12,552−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −1,175−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −480−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −116−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −61−100.0% | Sold out |